Product Code: PHA1326
The global Automation in Biopharma Industry market is projected to grow at a CAGR of 7% by 2034
The Automation in Biopharma Industry Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increased Machine Flexibility and Labour Shortages Driving Industry Growth
Pharmaceutical businesses expressed their desire to use automated solutions more frequently, with 75% stating as much. The primary cause of this, in addition to a labour shortage, is the shift towards injectable and more specialized drugs. Injectable, for instance, have expanded by about 100%, and until 2027, parenteral containers are anticipated to develop at a compound annual growth rate (CAGR) of 5.2%. Pharmaceutical production systems face hurdles from things such as pre-filled syringes and customised doses. So, in order to handle the greater diversity of formats generated in smaller batch sizes, manufacturers are searching for gear that can limit downtime.
Manufacturers were experiencing a shortage of both experienced and unskilled workers; nevertheless, as many producers are aware, conditions have deteriorated significantly in the past two years. In 2022, PMMI, the Packaging and Processing Technologies Association, published a white paper in which it stated that 33% of pharmaceutical businesses were having trouble staffing their operations. Automated technologies and robotics may be able to help pharmaceutical companies with their labour problem. The retirement of almost 80 million baby boomers and the arrival of only 40 million new workers into the labour force at the same time will result in a serious talent deficit over the next 30 years. In the biopharma industry alone, there are over 800,000 workers, but there are over 60,000 unfilled positions, indicating an 8% labour shortage.
What Questions Should You Ask Before Buying a Market Research Report?
How is the Automation in Biopharma Industry market evolving?
What is driving and restraining the Automation in Biopharma Industry market?
How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each Automation in Biopharma Industry submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading Automation in Biopharma Industry markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the Automation in Biopharma Industry projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of Automation in
Biopharma Industry projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the Automation in Biopharma Industry market?
Where is the Automation in Biopharma Industry market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Automation in Biopharma Industry market today, and over the next 10 years:
Our 364-page report provides 138 tables, 226 charts, and graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Automation in Biopharma Industry market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), impact of rising Automation in Biopharma Industry prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report
Technology
Automation Technology
Digitization Technology
Automation Technology
Supervisory Control and Data Acquisition (SCADA)
Distributed Control Systems (DCS)
Programmable Logic Controllers (PLC)
Manufacturing Execution System (MES)
Human-machine Interface (HMI)
Advanced Process Control (APC)
Enterprise Resource Planning (ERP)
Laboratory Information Management System (LIMS)
Customer Relationship Management (CRM)
Corrective and Preventive Actions (CAPA)
Other Automation Technologies
Digitization Technology
Internet of things (IoT)
Artificial Intelligence (AI)
Digital Twin Technology
Augmented Reality (AR) and Virtual Reality (VR)
Predictive Analytics
Cloud Computing
Application
Clinical Phase
Drug Discovery Phase
Production Phase
Component
Automation Hardware
Automation Software
Services Project Phase
Services Operation Phase
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Switzerland
Netherlands
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
South East Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
MEA
GCC
South Africa
Egypt
Rest of MEA
The report also includes profiles and for some of the leading companies in the Automation in Biopharma Industry Market, 2024 to 2034, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth
ABB
Acieta
ADLINK Technology Inc.
AMETEK, Inc.
Baumuller
Emerson Electric Co.
Revvity Inc.
RheoSense Inc.
Rockwell Automation
Sartorius AG
Siemens Healthineers AG
TetraScience, Inc.
Thermo Fisher Scientific Inc.
Overall world revenue for automation in biopharma industry market, 2024 to 2034 in terms of value the market will surpass US$1,950 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Automation in Biopharma Industry Market, 2024 to 2034 report help you?
In summary, our 360+ page report provides you with the following knowledge:
Revenue forecasts to 2034 for Automation in Biopharma Industry Market, 2024 to 2034, with forecasts for technology, automation technology, digitization technology, application component, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 25 key national markets - See forecasts for the Automation in Biopharma Industry Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Switzerland, Netherlands, China, India, Japan, Australia, South Korea, South East Asia, Argentina, GCC, South Africa, and Egypt among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the automation in biopharma industry market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Automation in Biopharma Industry Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Automation in Biopharma Industry Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report
- 1.6 Who is This Report for?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
2 Executive Summary
3 Industry Structure
- 3.1.1 Technology is at the Forefront
- 3.1.2 Automated Manufacturing
- 3.1.3 Digital Twin in Pharmaceutical Manufacturing
- 3.1.4 Process Modelling
- 3.1.5 Advanced Process Control
- 3.1.6 Regulatory Developments and Trends in Biopharma
- 3.2 Overview of Automation in Biopharma Industry 4.0
- 3.2.1 Types & Levels of Automation in Biopharma
- 3.2.2 Biopharma, Digital Applications, and Industry 4.0
- 3.2.2.1 Supply Chain
- 3.2.2.2 Streamlining Marketing Efforts
- 3.2.2.3 Acquiring Talent More Efficiently
- 3.2.3 Manufacturing and Supply Chain
- 3.2.4 Recent Trends & Developments
4 Market Overview
- 4.1 Key Findings
- 4.2 Market Dynamics
- 4.2.1 Market Driving Factors
- 4.2.1.1 Labour Shortages Comprising Both High- and Low-Skilled Workers
- 4.2.1.2 Need for Increased Machine Flexibility
- 4.2.1.3 Technological Advancements to Improve Product Safety
- 4.2.1.4 Increased Adoption of Electronic Batch Records
- 4.2.2 Market Restraining Factors
- 4.2.2.1 Need for High Capital Investment Limits the Market Expansion
- 4.2.2.2 Stringent Regulatory Norms to Challenge Market Growth
- 4.2.2.3 Smaller Datasets
- 4.2.3 Market Opportunities
- 4.2.3.1 Working Smarter Using Digital Labour
- 4.2.3.2 Robotics are Increasingly Regarded as Valuable to Operations
- 4.2.3.3 Faster Hypothesis to Testing Cycles
- 4.3 COVID-19 Impact Analysis
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Threat of Substitutes
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Bargaining Power of Buyers
- 4.4.5 Competitive Rivalry
- 4.5 SWOT Analysis
- 4.6 PESTLE Analysis
- 4.6.1 Political Factors Impacting Automation in Biopharma Industry Market
- 4.6.2 Economic Factors Impacting Automation in Biopharma Industry Market
- 4.6.3 Social Factors Impacting Automation in Biopharma Industry Market
- 4.6.4 Technological Factors Impacting Automation in Biopharma Industry Market
- 4.6.5 Legal Factors Impacting Automation in Biopharma Industry Market
- 4.6.6 Environmental Factors Impacting Automation in Biopharma Industry Market
- 4.7 Significance of Automation in the Pharmaceutical Industries
- 4.7.1 Automated Filling, Inspection, and Packaging
- 4.7.2 Making Personalised Medicines a Reality
- 4.7.3 Involving Robotics in the Laboratory
- 4.7.4 Continuous, Uninterrupted Manufacturing
- 4.7.5 Automatic Control
5 Automation in Biopharma Industry Market Analysis by Technology
- 5.1 Key Findings
- 5.2 Technology Segment: Market Attractiveness Index
- 5.3 Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
- 5.4 Automation Technology
- 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 5.4.2 Market Share by Region, 2024 & 2034 (%)
- 5.5 Digitization Technology
- 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 5.5.2 Market Share by Region, 2024 & 2034 (%)
6 Automation in Biopharma Industry Market by Automation Technology
- 6.1 Key Findings
- 6.2 Automation Technology Segment: Market Attractiveness Index
- 6.3 Automation in Biopharma Industry Market, by Automation Technology
- 6.4 Supervisory Control and Data Acquisition (SCADA)
- 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.4.2 Market Share by Region, 2024 & 2034 (%)
- 6.5 Distributed Control Systems (DCS)
- 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.5.2 Market Share by Region, 2024 & 2034 (%)
- 6.6 Programmable Logic Controllers (PLC)
- 6.6.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.6.2 Market Share by Region, 2024 & 2034 (%)
- 6.7 Manufacturing Execution System (MES)
- 6.7.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.7.2 Market Share by Region, 2024 & 2034 (%)
- 6.8 Human-machine Interface (HMI)
- 6.8.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.8.2 Market Share by Region, 2024 & 2034 (%)
- 6.9 Advanced Process Control (APC)
- 6.9.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.9.2 Market Share by Region, 2024 & 2034 (%)
- 6.10 Enterprise Resource Planning (ERP)
- 6.10.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.10.2 Market Share by Region, 2024 & 2034 (%)
- 6.11 Laboratory Information Management System (LIMS)
- 6.11.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.11.2 Market Share by Region, 2024 & 2034 (%)
- 6.12 Customer Relationship Management (CRM)
- 6.12.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.12.2 Market Share by Region, 2024 & 2034 (%)
- 6.13 Corrective and Preventive Actions (CAPA)
- 6.13.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.13.2 Market Share by Region, 2024 & 2034 (%)
- 6.14 Other Automation Technologies
- 6.14.1 Market Size by Region, 2024-2034 (US$ Million)
- 6.14.2 Market Share by Region, 2024 & 2034 (%)
7 Automation in Biopharma Industry Market by Digitization Technology
- 7.1 Key Findings
- 7.2 Digitization Technology Segment: Market Attractiveness Index
- 7.3 Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
- 7.4 Internet of Things (IoT)
- 7.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 7.4.2 Market Share by Region, 2024 & 2034 (%)
- 7.5 Artificial Intelligence (AI)
- 7.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 7.5.2 Market Share by Region, 2024 & 2034 (%)
- 7.6 Digital Twin Technology
- 7.6.1 Market Size by Region, 2024-2034 (US$ Million)
- 7.6.2 Market Share by Region, 2024 & 2034 (%)
- 7.7 Augmented Reality (AR) and Virtual Reality (VR)
- 7.7.1 Augmented Reality (AR) Technology
- 7.7.2 Virtual Reality (VR) Technology
- 7.7.3 Market Size by Region, 2024-2034 (US$ Million)
- 7.7.4 Market Share by Region, 2024 & 2034 (%)
- 7.8 Predictive Analytics
- 7.8.1 Market Size by Region, 2024-2034 (US$ Million)
- 7.8.2 Market Share by Region, 2024 & 2034 (%)
- 7.9 Cloud Computing
- 7.9.1 Market Size by Region, 2024-2034 (US$ Million)
- 7.9.2 Market Share by Region, 2024 & 2034 (%)
8 Automation in Biopharma Industry Market by Application
- 8.1 Key Findings
- 8.2 Application Type Segment: Market Attractiveness Index
- 8.3 Automation in Biopharma Industry Market by Application Forecast, 2024-2034
- 8.4 Clinical Phase
- 8.4.1 Market Size by Region, 2024-2034 (US$ Million)
- 8.4.2 Market Share by Region, 2024 & 2034 (%)
- 8.5 Drug Discovery Phase
- 8.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 8.5.2 Market Share by Region, 2024 & 2034 (%)
- 8.6 Production Phase
- 8.6.1 Market Size by Region, 2024-2034 (US$ Million)
- 8.6.2 Market Share by Region, 2024 & 2034 (%)
9 Automation in Biopharma Industry Market by Component
- 9.1 Key Findings
- 9.2 Component Segment: Market Attractiveness Index
- 9.3 Automation in Biopharma Industry Market Size Estimation and Forecast by Component
- 9.4 Automation Hardware
- 9.4.1 Processing equipment
- 9.4.2 Packaging Equipment
- 9.4.3 Market Size by Region, 2024-2034 (US$ Million)
- 9.4.4 Market Share by Region, 2024 & 2034 (%)
- 9.5 Automation Software
- 9.5.1 Market Size by Region, 2024-2034 (US$ Million)
- 9.5.2 Market Share by Region, 2024 & 2034 (%)
- 9.6 Services Project Phase
- 9.6.1 Market Size by Region, 2024-2034 (US$ Million)
- 9.6.2 Market Share by Region, 2024 & 2034 (%)
- 9.7 Services Operation Phase
- 9.7.1 Market Size by Region, 2024-2034 (US$ Million)
- 9.7.2 Market Share by Region, 2024 & 2034 (%)
10 Automation in Biopharma Industry Market Analysis by Region
- 10.1 Key Findings
- 10.2 Regional Market Size Estimation and Forecast
11 North America Automation in Biopharma Industry Market Analysis
- 11.1 Key Findings
- 11.2 North America Automation in Biopharma Industry Market Attractiveness Index
- 11.3 North America Automation in Biopharma Industry Market by Country, 2024, 2029 & 2034 (US$ Million)
- 11.4 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Country
- 11.5 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
- 11.5.1 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Automation Technology
- 11.5.2 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
- 11.6 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Application
- 11.7 North America Automation in Biopharma Industry Market Size Estimation and Forecast by Component
- 11.8 U.S. Automation in Biopharma Industry Market Analysis
- 11.9 Canada Automation in Biopharma Industry Market Analysis
12 Europe Automation in Biopharma Industry Market Analysis
- 12.1 Key Findings
- 12.2 Europe Automation in Biopharma Industry Market Attractiveness Index
- 12.3 Europe Automation in Biopharma Industry Market by Country, 2024, 2029 & 2034 (US$ Million)
- 12.4 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Country
- 12.5 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
- 12.5.1 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Automation Technology
- 12.5.2 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
- 12.6 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Application
- 12.7 Europe Automation in Biopharma Industry Market Size Estimation and Forecast by Component
- 12.8 Germany Automation in Biopharma Industry Market Analysis
- 12.9 UK Automation in Biopharma Industry Market Analysis
- 12.10 France Automation in Biopharma Industry Market Analysis
- 12.11 Italy Automation in Biopharma Industry Market Analysis
- 12.12 Spain Automation in Biopharma Industry Market Analysis
- 12.13 Switzerland Automation in Biopharma Industry Market Analysis
- 12.14 Netherlands Automation in Biopharma Industry Market Analysis
- 12.15 Rest of Europe Automation in Biopharma Industry Market Analysis
13 Asia Pacific Automation in Biopharma Industry Market Analysis
- 13.1 Key Findings
- 13.2 Asia Pacific Automation in Biopharma Industry Market Attractiveness Index
- 13.3 Asia Pacific Automation in Biopharma Industry Market by Country, 2024, 2029 & 2034 (US$ Million)
- 13.4 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Country
- 13.5 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
- 13.5.1 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Automation Technology
- 13.5.2 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
- 13.6 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Application
- 13.7 Asia Pacific Automation in Biopharma Industry Market Size Estimation and Forecast by Component
- 13.8 Japan Automation in Biopharma Industry Market Analysis
- 13.9 China Automation in Biopharma Industry Market Analysis
- 13.10 India Automation in Biopharma Industry Market Analysis
- 13.11 Australia Automation in Biopharma Industry Market Analysis
- 13.12 South Korea Automation in Biopharma Industry Market Analysis
- 13.13 South East Asia Automation in Biopharma Industry Market Analysis
- 13.14 Rest of Asia Pacific Automation in Biopharma Industry Market Analysis
14 Latin America Automation in Biopharma Industry Market Analysis
- 14.1 Key Findings
- 14.2 Latin America Automation in Biopharma Industry Market Attractiveness Index
- 14.3 Latin America Automation in Biopharma Industry Market by Country, 2024, 2029 & 2034 (US$ Million)
- 14.4 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Country
- 14.5 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
- 14.5.1 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Automation Technology
- 14.5.2 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
- 14.6 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Application
- 14.7 Latin America Automation in Biopharma Industry Market Size Estimation and Forecast by Component
- 14.8 Brazil Automation in Biopharma Industry Market Analysis
- 14.9 Mexico Automation in Biopharma Industry Market Analysis
- 14.10 Argentina Automation in Biopharma Industry Market Analysis
- 14.11 Rest of Latin America Automation in Biopharma Industry Market Analysis
15 MEA Automation in Biopharma Industry Market Analysis
- 15.1 Key Findings
- 15.2 MEA Automation in Biopharma Industry Market Attractiveness Index
- 15.3 MEA Automation in Biopharma Industry Market by Country, 2024, 2029 & 2034 (US$ Million)
- 15.4 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Country
- 15.5 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Technology
- 15.5.1 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Automation Technology
- 15.5.2 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Digitization Technology
- 15.6 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Application
- 15.7 MEA Automation in Biopharma Industry Market Size Estimation and Forecast by Component
- 15.8 GCC Automation in Biopharma Industry Market Analysis
- 15.9 South Africa Automation in Biopharma Industry Market Analysis
- 15.10 Egypt Automation in Biopharma Industry Market Analysis
- 15.11 Rest of MEA Automation in Biopharma Industry Market Analysis
16 Company Profiles
- 16.1 Competitive Landscape, 2023
- 16.2 Revvity Inc.
- 16.2.1 Company Snapshot
- 16.2.2 Company Overview
- 16.2.3 Financial Analysis
- 16.2.3.1 Net Revenue, 2019-2023
- 16.2.3.2 R&D, 2019-2023
- 16.2.3.3 Segment Market Shares, 2023
- 16.2.3.4 Regional Market Shares, 2023
- 16.2.4 Product Benchmarking
- 16.2.5 Strategic Outlook
- 16.3 Siemens Healthineers AG
- 16.3.1 Company Snapshot
- 16.3.2 Company Overview
- 16.3.3 Financial Analysis
- 16.3.3.1 Net Revenue, 2019-2023
- 16.3.3.2 R&D, 2019-2023
- 16.3.3.3 Segment Market Shares, 2023
- 16.3.3.4 Regional Market Shares, 2023
- 16.3.4 Product Benchmarking
- 16.3.5 Strategic Outlook
- 16.4 ABB
- 16.4.1 Company Snapshot
- 16.4.2 Company Overview
- 16.4.3 Financial Analysis
- 16.4.3.1 Net Revenue, 2019-2023
- 16.4.3.2 R&D, 2019-2023
- 16.4.3.3 Segment Market Shares, 2023
- 16.4.3.4 Regional Market Shares, 2023
- 16.4.4 Product Benchmarking
- 16.4.5 Strategic Outlook
- 16.5 Rockwell Automation
- 16.5.1 Company Snapshot
- 16.5.2 Company Overview
- 16.5.3 Financial Analysis
- 16.5.3.1 Net Revenue, 2019-2023
- 16.5.3.2 R&D, 2019-2023
- 16.5.3.3 Segment Market Shares, 2023
- 16.5.3.4 Regional Market Shares, 2023
- 16.5.4 Product Benchmarking
- 16.5.5 Strategic Outlook
- 16.6 Thermo Fisher Scientific Inc.
- 16.6.1 Company Snapshot
- 16.6.2 Company Overview
- 16.6.3 Financial Analysis
- 16.6.3.1 Net Revenue, 2018-2023
- 16.6.3.2 R&D, 2019-2023
- 16.6.3.3 Segment Market Shares, 2023
- 16.6.3.4 Regional Market Shares, 2023
- 16.6.4 Product Benchmarking
- 16.6.5 Strategic Outlook
- 16.7 Sartorius AG
- 16.7.1 Company Snapshot
- 16.7.2 Company Overview
- 16.7.3 Financial Analysis
- 16.7.3.1 Net Revenue, 2019-2023
- 16.7.3.2 R&D, 2019-2023
- 16.7.3.3 Segment Market Shares, 2023
- 16.7.3.4 Regional Market Shares, 2023
- 16.7.4 Product Benchmarking
- 16.7.5 Strategic Outlook
- 16.8 RheoSense Inc.
- 16.8.1 Company Snapshot
- 16.8.2 Company Overview
- 16.8.3 Product Benchmarking
- 16.8.4 Strategic Outlook
- 16.9 Emerson Electric Co.
- 16.9.1 Company Snapshot
- 16.9.2 Company Overview
- 16.9.3 Financial Analysis
- 16.9.3.1 Net Revenue, 2019-2023
- 16.9.3.2 R&D, 2019-2023
- 16.9.3.3 Segment Market Shares, 2023
- 16.9.3.4 Regional Market Shares, 2023
- 16.9.4 Product Benchmarking
- 16.9.5 Strategic Outlook
- 16.10 TetraScience, Inc.
- 16.10.1 Company Snapshot
- 16.10.2 Company Overview
- 16.10.3 Product Benchmarking
- 16.10.4 Strategic Outlook
- 16.11 ADLINK Technology Inc.
- 16.11.1 Company Snapshot
- 16.11.2 Company Overview
- 16.11.3 Financial Analysis
- 16.11.3.1 Net Revenue, 2018-2022
- 16.11.3.2 R&D, 2018-2022
- 16.11.3.3 Segment Market Shares, 2022
- 16.11.3.4 Regional Market Shares, 2022
- 16.11.4 Product Benchmarking
- 16.11.5 Strategic Outlook
- 16.12 Acieta
- 16.12.1 Company Snapshot
- 16.12.2 Company Overview
- 16.12.3 Product Benchmarking
- 16.12.4 Strategic Outlook
- 16.13 AMETEK, Inc.
- 16.13.1 Company Snapshot
- 16.13.2 Company Overview
- 16.13.3 Financial Analysis
- 16.13.3.1 Net Revenue, 2019-2023
- 16.13.3.2 Segment Market Shares, 2022
- 16.13.3.3 Regional Market Shares, 2022
- 16.13.4 Product Benchmarking
- 16.13.5 Strategic Outlook
- 16.14 Baumuller
- 16.14.1 Company Snapshot
- 16.14.2 Company Overview
- 16.14.3 Product Benchmarking
- 16.14.4 Strategic Outlook
17 Conclusion and Recommendations
- 17.1 Concluding Remarks from Visiongain
- 17.2 Recommendations for Market Players